Marisa Ames Ames, M. K., Vaden, S. L., Atkins, C. E., Palerme, J.-S., Langston, C. E., Grauer, G. F., … Webb, T. (2022, November 9). Prevalence of aldosterone breakthrough in dogs receiving renin-angiotensin system inhibitors for proteinuric chronic kidney disease. JOURNAL OF VETERINARY INTERNAL MEDICINE. https://doi.org/10.1111/jvim.16573 Ames, M. K., VanVranken, P., Evans, C., & Atkins, C. E. (2020). Non-Arsenical heartworm adulticidal therapy using topical moxidectin-imidacloprid and doxycycline: A prospective case series. VETERINARY PARASITOLOGY, 282. https://doi.org/10.1016/j.vetpar.2020.109099 Ames, M. K., & Atkins, C. E. (2020). Treatment of dogs with severe heartworm disease. VETERINARY PARASITOLOGY, 283. https://doi.org/10.1016/j.vetpar.2020.109131 Ames, M. K., Atkins, C. E., & Pitt, B. (2019). [Review of The renin-angiotensin-aldosterone system and its suppression]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 33(2), 363–382. https://doi.org/10.1111/jvim.15454 Ames, M. K., Atkins, C. E., Eriksson, A., & Hess, A. M. (2017). Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease. JOURNAL OF VETERINARY CARDIOLOGY, 19(3), 218–227. https://doi.org/10.1016/j.jvc.2017.03.001 Lantis, A. C., Ames, M. K., Atkins, C. E., Defrancesco, T. C., Keene, B. W., & Werre, S. R. (2015). Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 38(1), 65–73. https://doi.org/10.1111/jvp.12154 Ames, M. K., Atkins, C. E., Lee, S., Lantis, A. C., & zumBrunnen, J. R. (2015). Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs. AMERICAN JOURNAL OF VETERINARY RESEARCH, 76(12), 1041–1050. https://doi.org/10.2460/ajvr.76.12.1041 Schneider, J., Ames, M., DiCicco, M., Savage, M., Atkins, C., Wood, M., & Gookin, J. L. (2015). Recovery of normal esophageal function in a kitten with diffuse megaesophagus and an occult lower esophageal stricture. JOURNAL OF FELINE MEDICINE AND SURGERY, 17(6), 557–561. https://doi.org/10.1177/1098612x14542451 Lantis, A. C., Ames, M. K., Werre, S., & Atkins, C. E. (2015). The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 38(5), 513–517. https://doi.org/10.1111/jvp.12216 Reina-Doreste, Y., Stern, J. A., Keene, B. W., Tou, S. P., Atkins, C. E., DeFrancesco, T. C., … Meurs, K. M. (2014). Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 245(5), 534–539. https://doi.org/10.2460/javma.245.5.534 Meurs, K. M., Stern, J. A., Sisson, D. D., Kittleson, M. D., Cunningham, S. M., Ames, M. K., … Tou, S. P. (2013). Association of Dilated Cardiomyopathy with the Striatin Mutation Genotype in Boxer Dogs. JOURNAL OF VETERINARY INTERNAL MEDICINE, 27(6), 1437–1440. https://doi.org/10.1111/jvim.12163 Ames, M. K., Atkins, C. E., Lantis, A. C., & Were, S. R. (2013). Effect of furosemide and high-dosage pimobendan administration on the renin-angiotensin-aldosterone system in dogs. American Journal of Veterinary Research, 74(8), 1084–1090. https://doi.org/10.2460/ajvr.74.8.1084